Bauerlein Alison
- SEC CIK
- 0001596080
In the past year, 5 open-market sale filings worth $508.0K and no purchases.
Current role at each company
- SGHT Sight Sciences, Inc.Chief Operating Officeras of Jul 6, 2026
- PEAR Pear Therapeutics, Inc.Directoras of Feb 17, 2023
- GLSH Gelesis Holdings, Inc.Directoras of May 9, 2022
- INGN Inogen IncEVP, Finance, & CFOas of Dec 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $508.0K
- 5 filings
- Net
- −$508.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bauerlein Alison as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SGHT Sight Sciences, Inc.
Chief Operating Officer13 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 (view filing)7:32 PM ET | Jul 2 | 4 days | Bauerlein AlisonChief Operating Officer | SSale | −24.2K | $5.36 | −$129.6K | −3.5%664.7K after | 10b5-1 |
| May 19, 2026 (view filing) | May 18 | 1 day | Bauerlein AlisonChief Operating Officer | SSale | −12.7K | $5.12 | −$65.2K | −1.8%688.9K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Bauerlein AlisonChief Operating Officer | SSale | −25.9K | $3.48 | −$90.0K | −3.6%701.6K after | 10b5-1 |
| Jan 6, 2026 (view filing) | Jan 5-6 | 1 day | Bauerlein AlisonChief Operating Officer | SSale | −20.5K | $7.66 | −$157.4K | −3.3%600.0K after | 2 lots |
| Oct 3, 2025 (view filing) | Oct 2 | 1 day | Bauerlein AlisonChief Financial Officer | SSale | −19.9K | $3.30 | −$65.8K | −3.2%597.5K after | |
| Jul 7, 2025 (view filing) | Jul 2 | 5 days | Bauerlein AlisonChief Financial Officer | SSale | −19.3K | $4.10 | −$79.0K | −3.0%617.5K after | |
| May 21, 2025 (view filing) | May 19 | 2 days | Bauerlein AlisonChief Financial Officer | SSale | −13.1K | $3.48 | −$45.5K | −2.0%636.7K after | |
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Bauerlein AlisonChief Financial Officer | SSale | −19.4K | $2.31 | −$44.8K | −2.9%649.8K after | |
| Jan 6, 2025 (view filing) | Jan 3 | 3 days | Bauerlein AlisonChief Financial Officer | SSale | −10.1K | $3.52 | −$35.6K | −2.6%382.5K after | |
| Oct 3, 2024 (view filing) | Oct 1 | 2 days | Bauerlein AlisonChief Financial Officer | SSale | −10.1K | $6.08 | −$61.6K | −2.5%392.6K after |
INGN Inogen Inc
EVP, Finance, & CFO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2021 (view filing) | Dec 15, 2020 | 353 days | Bauerlein AlisonEVP, Finance, & CFO | SSale | −8.70K | $40.16 | −$349.5K | −21.1%32.5K after | Amended3 lots |
| Aug 3, 2021 (view filing) | Jul 30-Aug 2 | 4 days | Bauerlein AlisonEVP, Finance, & CFO | SSale | −9.63K | $80.06 | −$771.1K | −71.8%3.78K after | 2 lots |
| Jul 29, 2021 (view filing) | Jul 27 | 2 days | Bauerlein AlisonEVP, Finance, & CFO | SSale | −9.63K | $75.02 | −$722.6K | −71.8%3.78K after |